EMILY GOLDSWORTHY: Open Payments
NPI 1801513460 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 17 payments from 9 companies in 2025. Trend: 2023 $678 · 2024 $679 · 2025 $548
Food & beverage: $530Education: $18
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 3 | $183 |
| BridgeBio Pharma, Inc. | 1 | $94 |
| Amgen Inc. | 4 | $71 |
| AstraZeneca Pharmaceuticals LP | 3 | $69 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Medtronic, Inc. | 1 | $18 |
Products named: AMVUTTRA, Attruby, REPATHA, WAINUA, LEQVIO, ONPATTRO, JARDIANCE, NEXLETOL.
Industry payments across PA — which companies pay providers there.
